PureTech Health (LON:PRTC) Stock Crosses Above 50-Day Moving Average - Time to Sell?

Key Points

• PureTech Health plc stock has surpassed its 50-day moving average, trading at GBX 142.80 ($1.93) with a high of GBX 144 ($1.95) during recent trading sessions.
• The company has a market capitalization of £431.95 million and is currently experiencing an increased interest from insiders, with notable purchases by a corporate insider.
• PureTech Health specializes in developing medicines for nervous, gastrointestinal, and immune system disorders, showcasing its commitment to addressing immune-mediated diseases and other health concerns.

PureTech Health plc (LON:PRTC - )'s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 133.79 ($1.81) and traded as high as GBX 144 ($1.95). PureTech Health shares last traded at GBX 142.80 ($1.93), with a volume of 593,255 shares traded.

PureTech Health Trading Up 0.7%

The firm has a market cap of £431.95 million, a P/E ratio of -5.90 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The stock has a 50 day moving average of GBX 133.79 and a 200 day moving average of GBX 134.33.

Insider Buying and Selling

In other news, insider Bharatt Chowrira bought 167,739 shares of PureTech Health stock in a transaction that occurred on Thursday, July 3rd. The shares were acquired at an average price of GBX 1 ($0.01) per share, with a total value of £1,677.39 ($2,265.82). 15.93% of the stock is currently owned by corporate insiders.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.